http://heu-uct.org.za/the-costs-of-hiv-health-care/ School of Public Health & Family Medicine Tue, 09 Mar 2010 12:07:26 +0000 http://wordpress.org/?v=2.9.1 hourly 1 http://heu-uct.org.za/the-costs-of-hiv-health-care/comment-page-1/#comment-62 Allison Tue, 09 Mar 2010 12:07:26 +0000 http://heu-uct.org.za/?p=1380#comment-62 This blog is a summary of a published journal article, for a broader and more detailed discussion of the terminology and key findings, please refer to www.plosmedicine.org. The title was: Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis. This blog is a summary of a published journal article, for a broader and more detailed discussion of the terminology and key findings, please refer to http://www.plosmedicine.org. The title was: Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis.

]]> http://heu-uct.org.za/the-costs-of-hiv-health-care/comment-page-1/#comment-61 Capetown Carework Sun, 07 Mar 2010 19:51:29 +0000 http://heu-uct.org.za/?p=1380#comment-61 1) Who's to say that the investment in "monitor[ing]" equipment, and the upkeep thereof, will not actually lead not to a reduction in "later" costs, but an increase? Sounds like a bit of a wager, too much current costing/projecting expenses absent to really vote on Part II, above. But, Re Part I, yes, it does read as though early ART's could reasonably "lead to overall cost increases in the long run as patients could live for longer" -- but of course that raises the ethical issue/question of, "but isn't longer life the aim?" Careful balance is key, here. This terminology seems to be lacking. 1) Who’s to say that the investment in “monitor[ing]” equipment, and the upkeep thereof, will not actually lead not to a reduction in “later” costs, but an increase? Sounds like a bit of a wager, too much current costing/projecting expenses absent to really vote on Part II, above. But, Re Part I, yes, it does read as though early ART’s could reasonably “lead to overall cost increases in the long run as patients could live for longer” — but of course that raises the ethical issue/question of, “but isn’t longer life the aim?” Careful balance is key, here. This terminology seems to be lacking.

]]>